Literature DB >> 10458522

Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage.

A V Vergoni1, A Bertolini, J E Wikberg, H B Schiöth.   

Abstract

CRF and melanocortin (MSH/ACTH) peptides share a number of central effects including anorexia and grooming. The effects of CRF may be secondary, due to CRF's effects on melanocortin peptide release. We investigated if the newly discovered selective melanocortin 4 receptor antagonist HS014 could influence CRF induced anorexia and grooming. The data show that ICV administration of CRF (3 mg/rat), significantly reduced food intake, feeding time and feeding episodes whereas it increased grooming time and grooming episodes. HS014 (5 mg/rat), that previously has been shown to antagonize the anorectic effect and the excessive grooming induced by alpha-MSH, did however not influence any of the behavioral effects induced by CRF when the peptides were administered together. The data indicate that the anorectic and grooming effects of CRF are independent of pathways involving the MC4 receptors. These data suggest that the anorectic and grooming effect of CRF are not due to a secondary effect caused by increase in release of melanocortins acting on the central MC receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458522     DOI: 10.1016/s0196-9781(99)00022-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  A functional continuum of regulatory anxiety-enhancing peptides. The search for complexes providing the optimal basis for developing inhibitory therapeutic agents.

Authors:  S V Koroleva; I P Ashmarin
Journal:  Neurosci Behav Physiol       Date:  2006-02

Review 2.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

3.  The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Peptides       Date:  2010-06-25       Impact factor: 3.750

4.  Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors.

Authors:  Koji Yakabi; Masamichi Noguchi; Shino Ohno; Shoki Ro; Tsuneko Onouchi; Mitsuko Ochiai; Hidehiko Takabayashi; Kiyoshige Takayama; Yumi Harada; Chiharu Sadakane; Tomohisa Hattori
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-03       Impact factor: 4.310

5.  The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.

Authors:  Silvia Vidali; Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Renaud Vatrinet; Andreas Koller; Felix Locker; Tricia Rutherford; Maura O'Donnell; Andrea Stöger-Kleiber; Bridget Lambert; Thomas Klaus Felder; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2017-07-17

6.  Usefulness of a Kampo Medicine on Stress-Induced Delayed Gastric Emptying in Mice.

Authors:  Sachiko Mogami; Ryutaro Arita; Miwa Nahata; Naoki Fujitsuka; Shin Takayama; Tadashi Ishii
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-31       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.